Skip to main content

Table 1 Clinical characteristics of the study groups

From: Deterioration in saliva quality in patients with Sjögren’s syndrome: impact of decrease in salivary epidermal growth factor on the severity of intraoral manifestations

 

SS (n = 40)

Non-SS (n = 23)

p value

Age (years)

55.4 ± 13.2

56.1 ± 17.4

0.425

Sex (male/female, number)

3:37

5:18

0.129

Disease duration (years)

5.6 ± 3.7 (n = 24)

Salivary flow rate (mL/10 min)

7.8 ± 4.4

16.9 ± 5.9

< 0.0001

OHIP-14 score (out of 56)

11.3 ± 9.4 (n = 35)

7.1 ± 7.6

0.037

Salivary EGF output (pg/10 min)

9237.6 ± 8447.0

13,296.9 ± 7907.1

0.033

  1. Mean ± SD
  2. SS Sjögren’s syndrome, OHIP-14 Oral Health Impact Profile-14